News | October 25, 2007

GE to Feature Imaging Modality Offerings

October 26, 2007 - GE Healthcare will feature its LightSpeed, Discovery VCT, PET VCAR. AdvantageSIM MD and Signa MR scanners at ASTRO 2007.

Both multi-slice, wide-bore CT scanners, the LightSpeed RT and RT 16 offer ample wide-bore capacities, thin, high-resolution multi-slice imaging, 4D retrospective respiratory gating capability and advanced oncology applications that simplify radiation therapy planning.

The Discovery VCT offers a complete set of clinical applications to help physicians provide accurate disease diagnosis, staging, treatment planning and follow up a single, less invasive tool for efficient evaluation of disease.
Also featured is GE Healthcare’s next-generation volume PET/CT application, which helps clinicians diagnose, stage, treat and monitor tumors and other lesions in the body. PET VCAR (Volume Computer-Assisted Reading) is designed to optimize tumor management, allowing for early quantification and understanding of treatment effectiveness for optimal treatment planning.

The AdvantageSim MD provides a revolutionary planning environment to help clinicians improve treatment planning, optimize the use of high-precision therapeutic techniques in routine clinical practice while helping prepare for radiation treatment techniques and processes on the horizon.

GE's Signa MR scanners, available in 1.5T or 3.0T, provide fast, high-resolution imaging. The imaging provides excellent soft-tissue resolution for definition of tumor boundaries and critical structures, while MR spectroscopy enables tumor characterization.

For more information: www.gehealthcare.com

Related Content

Study Explores Magnetic Nanoparticles as Bimodal Imaging Agent for PET/MRI

Image courtesy of MR Solutions.

News | PET-MRI | May 23, 2019
Researchers from Bourgogne University in Dijon, France, showed that use of superparamagnetic iron oxide nanoparticles (...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
MaxQ AI Launches Accipio Ax Slice-Level Intracranial Hemorrhage Detection
Technology | Computer-Aided Detection Software | May 21, 2019
Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that Accipio Ax will begin shipping in August...
AI Detects Unsuspected Lung Cancer in Radiology Reports, Augments Clinical Follow-up
News | Artificial Intelligence | May 20, 2019
Digital Reasoning announced results from its automated radiology report analytics research. In a series of experiments...
Baylor Scott White Heart Hospital Siemens Flash CT system used for dedicated cardiac CT scans, CCTA, CTA.
360 Photos | CT Angiography (CTA) | May 20, 2019
This is a 360 degree photo of a Siemens Somatom Force 64-slice, dual-source computed tomography (CT) system installed
New Study Evaluates Head CT Examinations and Patient Complexity
News | Neuro Imaging | May 17, 2019
Computed tomography (CT) of the head uses special X-ray equipment to help assess head injuries, dizziness and other...
New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in...
FDA Clears Aidoc's AI Solution for Flagging Pulmonary Embolism
Technology | Artificial Intelligence | May 15, 2019
Artificial intelligence (AI) solutions provider Aidoc has been granted U.S. Food and Drug Administration (FDA)...
Blue Earth Diagnostics Expands Access to Axumin in Europe
News | Radiopharmaceuticals and Tracers | May 13, 2019
Blue Earth Diagnostics announced expanded access to the Axumin (fluciclovine (18F)) imaging agent in Europe. The first...